At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
Lens A (ocufilcon D) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere
In Brief
A clinical study evaluating Lens A (ocufilcon D) and Lens B (fanfilcon A) for Ametropia. Completed, enrolled 44 participants across 1 site.
Detailed Summary
The aim of this study is to compare the short-term clinical performance of two sphere contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia
CountriesMexico
CollaboratorsCentre for Ocular Research & Education, Canada
Timeline
N/ACompletedFinished
20252026
Enrollment StartApr 2024
First PostedMay 2024
Primary CompletionMay 2024
TodayJul 2026
First PostedMay 6, 2024
Enrollment StartApr 3, 2024
Primary CompletionMay 11, 2024
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 2.2 years ago
Interventions
Lens A (ocufilcon D)device
15 minutes of daily wear.
Lens B (fanfilcon A)device
15 minutes of daily wear.